Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
TAIPEI, Taiwan, Oct. 25, 2017 -- With the aim to promote medical technology and devices in Taiwan and to connect to the world, the Medical Electronics and Device in Taiwan (MEDiT) Forum 2017 took place on October 25 and 26. Themed with "Multi-disciplinary Innovations in Healthcare”, this year’s forum invited participants such as Fujitsu, Advantech, and Qisda to share smart biomedical technology and market trends. It is hoped that this forum can facilitate cross-field industrial integration. By utilizing Taiwan’s strength in ICT, industries can grasp the medical trends in aging societies and the emerging medical device market to secure a spot in the global platform.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/110165d6-069c-4b70-98b5-899ce7cafe90
To promote innovation in the biomedical industry, Taiwan continues to reinforce the R&D investment in biotechnology innovation, develop pharmaceutical products for niche markets, and focus on systemized and intelligent medical devices, in the hope of making Taiwan the hub of biomedical technology innovation in Asia-Pacific. According to an official report on the 2017 biotechnology industry in Taiwan, the 2016 output value of the industry in Taiwan amounted to NT$315 billion, an increase of 5.5% to last year. The output value of medical devices, in particular, increased by 6.4% and reached NT$141.5 billion. If Taiwan can take advantage of its industrial clusters, it will be looking at a promising goal of NT$200 billion in medical device output value by 2020.
This year marks the 10th year of MEDiT. As a grand forum in Taiwan's medical device industry, each year, MEDiT proposes a theme in accordance with current market demands. It helps manufacturers build industrial clusters and make way into the global value chain, bringing them closer to the latest trends. Leading medical device manufacturers such as GE, Philips Healthcare, Siemens, Medtronic, J&J, and Roche Group all participated in this forum. The aim is to establish business ties and grasp industrial opportunities through this event.
Media Contact Chloe Chen Office of Marketing Communications, ITRI [email protected], +886-(0)3-5918167
